Observational studyInfluenza and other respiratory viruses2026
Incidence of Respiratory Syncytial Virus Infection Among Patients Aged Less Than 2 Years: A Retrospective Study From an Italian Southern Region in Years 2018-2023.
Observational study in Influenza and other respiratory viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hospital Admissions for Respiratory Syncytial Virus (RSV) Among Elderly: A Retrospective Study From an Italian Southern Region During Years 2018-2023.Influenza and other respiratory viruses · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRespiratory syncytial virus (RSV) is one of the most common viruses infecting nearly all children worldwide within the first 2 years of life, requiring hospitalization for over 80% of cases in infants under the age of 1. The aim of this study was to evaluate the epidemiological impact of RSV infections on hospital admissions among patients aged less than 2 years in the Abruzzo region, Italy. In addition, the analysis on patients aged less than 1 year and the evaluation of direct costs related to RSV admissions were also performed.
methodsA retrospective observational study was performed in Abruzzo, a Southern Italian region. Data related to hospitalizations were extracted from the hospital discharge record (HDRs) of the Abruzzo region, considering all hospitalizations registered from 2018 to 2023. HDRs from patients younger than 2 years of age and diagnosed with RSV were extracted. Hospitalizations were stratified by calendar year and seasonal cycle. In addition, the analysis of costs generated by each admission was performed.
resultsTotally, 1899 hospitalizations for RSV (98.43 admissions/1000 inhabitants aged under 2 years of age) were recorded in the Abruzzo region during the study period. The median length of stay of all the considered hospitalizations was 5 days (IQR 5-5). The year with the highest number of hospitalizations was 2023. The incident rate among patients under 2 years of age rose from 17.42 to 19.39 in 2023 in A2 over 1000 inhabitants. About costs, the total expenditure for hospitalizations strongly increased from €579,047.29 in 2018 to €1,060,018.94 in 2023.
conclusionsThis study highlights the heavy burden of RSV on hospital admissions among patients aged under 2 years in a region of Southern Italy. These results are in line with previously published research, leading to the necessity of the introduction of effective preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.